Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage

International Journal of Oncology

Volumn 33, Issue 4, 2008, Pages 689-696

  Usuda, Jitsuo ^a   Hirata, Takeshi ^a   Ichinose, Shuji ^a   Ishizumi, Taichirou ^a   Inoue, Tatsuya ^a   Ohtani, Keishi ^a   Maehara, Sachio ^a   Yamada, Masae ^a   Tsutsui, Hidemitsu ^a   Okunaka, Tetsuya ^b   Kato, Harubumi ^a   Ikeda, Norihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Bcl 2 photodamage; NPe6; Personalized medicine; Photodynamic therapy; Photofrin; Tailor made approach

Indexed keywords

GREEN FLUORESCENT PROTEIN; NPE 6; PHOTOFRIN; PROCASPASE 3; PROTEIN BCL 2; TALAPORFIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL KILLING; CELL STRAIN MCF 7; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; JAPAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS; DNA; DNA DAMAGE; HUMANS; LASERS; LIGHT; MEDICAL ONCOLOGY; MICROSCOPY, FLUORESCENCE; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION;

EID: 54049137996     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000054     Document Type: Article

References (31)

1. Dougherty TJ, Gomer CJ, Barbara WH, et al: Photodynamic therapy. J Natl Cancer Inst 90: 889-905, 1998.
2. Henderson BW and Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 55: 145-157, 1992.
3. Dougherty TJ: Photoradiation therapy for the treatment of malignant tumors. Cancer Res 36: 2628-2635, 1978.
4. Oleinick NL, Morris RL and Belichenko I: The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 1: 1-21, 2001.
5. Gomer CJ, Ferrario A, Luna M, et al: Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment. Lasers Surg Med 38: 516-521, 2006.
6. Dougherty TJ: An update on photodynamic therapy applications. J Clin Laser Med Surg 20: 3-7, 2002.
7. Usuda J, Kato H, Okunaka T, et al: Photodynamic therapy for lung cancers. J Thorac Oncol 1: 489-493, 2006.
8. Kato H, Usuda J, Okunaka T, et al: Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital. Lasers Surg Med 38: 371-375, 2006.
9. Kato H, Furukawa K, Sato M, et al: Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorine e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 42: 103-111, 2003.
10. Usuda J, Tsutsui H, Honda H, et al: Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy. Lung Cancer 58: 317-323, 2007.
11. Usuda J, Chin SM, Murphy ES, et al: Domain-dependent photodamage to Bcl-2: A membrane anchorage region is needed to form the target of phthalocyanine photosensitization. J Biol Chem 278: 2021-2029, 2003.
12. Usuda J, Azizuddin K, Chiu SM, et al: Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem Photobiol 78: 1-8, 2003.
13. Kessel D, Luo Y, Mathieu P, et al: Determinants of the apoptotic response to lysosomal photodamage. Photochem Photobiol 71: 196-200, 2000.
14. Reiners JJ, Caruso JA, Mathieu P, et al: Release of cytochrome c and activation of procaspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ 9: 934-944, 2002.
15. Usuda J, Okunaka T, Furukawa K, et al: Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis. Int J Cancer 93: 475-480, 2001.
16. Okunaka T, Usuda J, Ichinose S, et al: A possible relationship between the anti-cancer potency of photodynamic therapy using the novel photosensitizer ATX-s10-Na(II) and expression of the vascular endothelial growth factor in vivo. Oncol Rep 18: 679-683, 2007.
17. Ichinose S, Usuda J, Hirata T, et al: Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s 10(Na). Int J Oncol 29: 349-355, 2006.
18. Xue LY, Chin SM and Oleinick NL: Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 20: 3420-3427, 2001.
19. Xue LY, Chiu SM, Azizuddin K, et al: The depth of human cancer cells following photodynamic therapy: Apoptosis competence is necessary for Bcl-2 protection but not for induction of autophagy. Photochem Photobiol 83: 1016-1023, 2007.
20. Cheng EHY, Kirsch DG, Clen RJ, et al: Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968, 1997.
21. Kirsch DG, Doseff A, Chau BN, et al: Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 274: 21155-21161, 1999.
22. Ferrario A, von Tiehil KF, Rucker N, Schwartz MA, Gill PS and Gomer CJ: Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 60: 4066-4069, 2000.
23. Korbelik M: PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 38: 500-508, 2006.
24. Gollnick SO, Owczarczak B and Maier P: Photodynamic therapy and anti-tumor immunity. Lasers Surg Med 38: 509-515, 2006.
25. Amaravadi RK and Thompson CB: The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 13: 7271-7279, 2007.
26. Kessel D, Vicente HG and Reiners JJ: Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med 38: 482-488, 2006.
27. Kessel D and Reiners J: Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage. Photochem Photobiol 83: 1024-1028, 2007.
28. Saeki K, You A, Okuma E, et al: Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemia HL-60 cells. Cell Death Differ 7: 1263-1269, 2000.
29. Pattingre S, Tassa A, Qu X, et al: Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 122: 927-939, 2005.
30. Kawaguchi T, Yamamoto S, Naka N, et al: Immunohistochemical analysis of bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy. Br J Cancer 82: 418-423, 2000.
31. Ohnuma Y, Aoe M, Andou A, et al: Telomerase activity and Bcl-2 expression in non-small cell lung cancer. Clin Cancer Res 6: 2980-2987, 2000.